Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Oncotarget|November 16, 2017
ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibitionGary K Scott, David Chu, Ravneet Kaur, et al.
Cancer Research|September 19, 2007
Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformationHiroyuki Konishi, Bedri Karakas, Abde M Abukhdeir, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2025
Pan-Cancer Analyses Reveal Disparities in Tumor Genomic Profiles by Race/Ethnicity, Age, and SexWanqing Wen, Jungyoon Choi, Bhuminder Singh, et al.
Communications Biology|July 13, 2021
Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repairJustin Zonneville, Moyi Wang, Mohammed M Alruwaili, et al.
Journal of Proteome Research|August 13, 2015
Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine PhosphoproteomeMuhammad Saddiq Zahari, Xinyan Wu, Brian G Blair, et al.
JCO Precision Oncology|June 20, 2022
Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast CancerMinetta C Liu, Matthew MacKay, Matthew Kase, et al.
International Journal of Radiation Oncology, Biology, Physics|July 11, 2023
Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical TrialMeridith L Balbach, Alexander D Sherry, Brent N Rexer, et al.
The Journal of Biological Chemistry|May 9, 2006
Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cellsYi Huang, Judith C Keen, Allison Pledgie, et al.
Pageof 12